Indiana consistently lands near the bottom of the nation’s health ranking lists, with too many babies dying before their first birthday and too many people smoking and abusing drugs. The
By IU School of Medicine and CTSI Staff Reports: Indiana CTSI-supported research led by two Indiana University School of Medicine faculty members has culminated in U.S. Food and Drug Administration approval of
Changes are coming soon to two Indiana CTSI websites. CTSI Homepage Our homepage is getting an updated look and feel to better reflect our institute’s mission and story, as well
By Laurie Trevino: It is with mixed emotions and sincere gratitude for her service that we are announcing the retirement of Sharon Cromer, administrative manager for the Indiana CTSI Clinical
By April Toler: Naloxone, the opioid overdose reversal medication, can save lives, as reflected by the U.S. surgeon general’s recent advisory that Americans carry it and know how to use. But
By Erin Blasko: The University of Notre Dame is partnering with Ready to Grow St. Joe to assess the social, emotional, physical and cognitive development of children age birth to eight
The Indiana CTSI has made available a shared license for QIAGEN’s Ingenuity Pathway Analysis (IPA), a powerful analysis and search tool that uncovers the significance of ‘omics data and identifies
Indiana University School of Medicine scientist and transplant surgeon Burcin Ekser, MD, PhD, will boost his lab’s xenotransplantation, or cross-species transplantation, research program with a four-year, $9 million research agreement with
IU Researchers Using CTSI 3D Bioprinting Core to Study Organs Indiana CTSI e-newsletter content from May 2018 Indiana University School of Medicine scientist and transplant surgeon Burcin Ekser, MD, PhD,
Anantha Shekhar, MD, PhD, director of the Indiana CTSI, speaks at the CTSI’s opioid conference April 25 at IU Bloomington. Scientists, policy-makers and community members from across Indiana recently gathered